Christopher Lynch’s article, “Federal Rescheduling Sets The Stage For Marijuana Business Acquisitions As Pharma And Ag Firms Eye Industry (Op-Ed)," was published in Marijuana Moment.

Christopher Lynch’s article, “Federal Rescheduling Sets The Stage For Marijuana Business Acquisitions As Pharma And Ag Firms Eye Industry (Op-Ed),” published in Marijuana Moment, discusses that FDA-approved or state-licensed medical marijuana, from Schedule I to Schedule III, indicates accepted medical use and lower potential for abuse. “The practical question isn’t whether this is something to celebrate, it’s whether your business is positioned to be a consolidator, an attractive acquisition target or something different,” Chris says. To read more, click here.